Patrycja Ucieklak

Patrycja Ucieklak

Auto-generated profile, based on publicly available information

Patrycja Ucieklak

District Hospital in Zawiercie, Zawiercie, Poland

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 September 2025 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
TUTomasz Andrzej Ufniarski
Tomasz Andrzej Ufniarski
MUMaria Ufniarska
Maria Ufniarska
APAleksandra Piech
Aleksandra Piech
KPKarolina Pasierb
Karolina Pasierb
KPKarol Poplicha
Karol Poplicha
PUPatrycja Ucieklak
Patrycja Ucieklak
This narrative review examines whether Large Language Model (LLM)–based chatbots can help close the global mental health treatment gap while weighing their public-health risks. We synthesize peer-reviewed studies and relevant case reports to: (1) map the dimensions of the mental health treatment gap, (2) describe how recent LLM advances have changed chatbot capabilities, (3) explore how chatbots can address the dimensions of the gap, (4) evaluate evidence for clinical effectiveness, and (5) outline major safety, ethical, and policy concerns. Findings indicate that chatbots offer scalable, always-available, and low-cost support that can reduce barriers related to stigma, geographic and temporal access, affordability, and mental-health awareness. We found that the evidence supports chatbot interventions’ efficiency in small-to-moderate short-term reductions in depression and anxiety symptoms, while the long-term effects and use in other disorders remain largely unexplored. However, LLM chatbots also present clear risks: hallucinations and clinically inappropriate responses, amplification of stigma or bias, user dependence, and significant data-security vulnerabilities. Importantly, most widely used generalist LLMs lack rigorous clinical validation. We conclude that LLM chatbots are a persistent feature of the mental-health ecosystem whose benefits can be realized only with robust safety guardrails, transparent evaluation, integration into stepped-care pathways, and proactive regulation.

19 September 2025 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
PUPatrycja Ucieklak
Patrycja Ucieklak
JUJarosław Ucieklak
Jarosław Ucieklak
KPKarol Poplicha
Karol Poplicha
KPKonrad Poplicha
Konrad Poplicha
PSPiotr Sobkiewicz
Piotr Sobkiewicz
KPKarolina Pasierb
Karolina Pasierb
Introduction: Promoting natural labour with less medical interventions is one of main goals in modern obstetrics. Natural methods have gained more attention in recent years due to their potential to enhance cervical readiness, decrease the need for labour augmentation and shorten labour duration. Objective: This review aims to investigate the current clinical evidence on the effects of date fruits consumption during late pregnancy on childbirth stages and postpartum complications, particularly concentrating on cervical dilation upon hospital admission, frequency of spontaneous labour onset, and duration of different labour phases. Material and methods: A narrative review of 6 different randomized controlled trials and cohort studies investigating the impact of daily date intake in late-stage pregnancy on labour-related outcomes was conducted. Data that were extracted included cervical dilatation at hospital admission, frequency of spontaneous labour, need for oxytocin augmentation, and duration of all labour’s phases. Results: It was found that consumption of around 6–7 dates per day for 2-4 weeks before the estimated delivery date leads to increased cervical dilatation upon hospital admission, higher rates of spontaneous labour onset, shorter duration of all stages of labour (especially the latent and active phases of the first stage of delivery), and reduced need for oxytocin augmentation. Conclusions: Date fruit consumption appears to be a safe, easily accessible and natural intervention that may positively influence the initiation and progression of labour. However, large, well-designed trials in more diverse populations need to be conducted to further confirm these findings and to establish evidence-based guidelines.

30 September 2025 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
MGMartyna Grodzińska
Martyna Grodzińska
PSPiotr Sobkiewicz
Piotr Sobkiewicz
KPKarol Poplicha
Karol Poplicha
MUMaria Ufniarska
Maria Ufniarska
APAleksandra Piech
Aleksandra Piech
JUJarosław Ucieklak
Jarosław Ucieklak
Anorexia nervosa is a group of symptoms based on conscious restriction of food intake. Anorexia disrupts the body's homeostasis, so that the functioning of many organs is impaired. These dysfunctions involve the neuroendocrine system, the cardiovascular system, the skeletal system, the digestive system, and the reproductive system. Knowing the symptoms makes it possible to make an accurate diagnosis at an early stage of the disease. This is especially important given the increasing incidence and mortality rates. This article reviews the main clinical manifestations of AN. Attention is given to both pharmacotherapies and psychotherapy. The aim of the study: The purpose of this paper is to summarize the existing knowledge on mental anorexia nervosa. The article presents etiology, epidemiology, diagnosis, differentiation, clinical picture and treatment. The topic of eating disorders in pregnant women is also described. Material and method: In our article we used English databases such as PubMed and Google Scholar. We selected the articles according to key words such as eating disorders, osteoporosis, cardiomyopathy, hypoglycemia, psychotherapy, medical assessment, treatment. Conclusions: Eating disorders are a topic that unites many medical disciplines. The array of symptoms accompanying the disease clearly demonstrates the correlation of mental health with somatic health. Negative effects affect the skeletal system, neuroendocrine system, cardiovascular system, gastrointestinal system and reproductive system. Treatment is based on the use of pharmacotherapy, mainly using SSRI group drugs, as well as psychotherapy. A particularly appreciated current, among specialists, is cognitive-behavioral therapy.

30 September 2025 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
PUPatrycja Ucieklak
Patrycja Ucieklak
MUMonika Ucieklak
Monika Ucieklak
JUJarosław Ucieklak
Jarosław Ucieklak
DMDawid Musialik
Dawid Musialik
KPKarol Poplicha
Karol Poplicha
KPKarolina Pasierb
Karolina Pasierb
Background: Pacifier use remains a common practice during infancy and early childhood worldwide that has both benefits and risks. Its use has become highly prevalent in recent years and is sometimes considered overused, as it provides an easy and convenient method for calming and soothing children. Objective: This review aims to summarize current scientific evidence regarding pacifier use focusing on both positive and negative outcomes to provide an overview that may help with the establishment of the clinical recommendations. Methods: A narrative review of different randomized controlled trials and cohort studies investigating the positive and negative impacts of pacifier use such as SIDS risk, pain management, otitis media, dental malocclusions and breast-feeding. Results: The reviewed studies indicate that pacifier use reduces risk of sudden infant death syndrome (SIDS) and is an effective way of pain management during minor medical procedures. However, evidence shows an association between pacifier use and increased incidence of acute otitis media, dental malocclusions in cases of prolonged use and negative impact on breastfeeding when introduced before lactation is well established. Conclusion: The evidence supports selective use of pacifier, particularly during the first year of life with its introduction delayed until breastfeeding is well established, which happens usually around 1 month of age. Its use should be limited mainly to sleep periods and gradually limited by 12 months of age. Proper timing and restricted duration are key to maximising benefits while reducing risks.

16 September 2025 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
APAleksandra Piech
Aleksandra Piech
KPKarolina Pasierb
Karolina Pasierb
TUTomasz Andrzej Ufniarski
Tomasz Andrzej Ufniarski
MGMartyna Grodzińska
Martyna Grodzińska
MUMaria Ufniarska
Maria Ufniarska
PUPatrycja Ucieklak
Patrycja Ucieklak
Venous thromboembolism (VTE), which consists of deep vein thrombosis (DVT) and pulmonary embolism (PE), is one of the most common cardiovascular diseases. Despite improvements in prevention, diagnosis, and treatment, its mortality rates are still high and remain a major problem in public health. The World Health Organization (WHO) recommends that adults (aged 18–64 years) engage in at least 150–300 minutes of moderate-intensity aerobic physical activity or 75–150 minutes of vigorous-intensity aerobic activity per week. Prolonged sedentary behavior contributes to increased venous compression in the lower extremities, leading to reduced venous return and an elevated risk of VTE. Many studies have observed a risk increase of up to 2-10% per additional hour of prolonged sitting. In the literature, a positive correlation was found between higher levels of PA and reduced risk of VTE, indicating a significant reduction in risk for those with higher levels of PA, even at levels below norms established by the WHO. However, some research indicates that the highest level of physical exertion—defined as regularly engaging in hard physical training (i.e., vigorous exercise or participation in competitive sports several times per week)—was associated with a twofold increased risk of first-time VTE. The aim of this review is to provide a general overview of the impact of physical activity on venous thromboembolism. Material and method: A review of available literature from the PubMed database from 2005 to 2024.

11 September 2025 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
KPKarol Poplicha
Karol Poplicha
PSPiotr Sobkiewicz
Piotr Sobkiewicz
APAleksandra Piech
Aleksandra Piech
KPKonrad Poplicha
Konrad Poplicha
PUPatrycja Ucieklak
Patrycja Ucieklak
JUJarosław Ucieklak
Jarosław Ucieklak
Background: There is growing evidence to support an association between the SARS-CoV-2 infection and the onset or flare of ADs (autoimmune diseases) in pediatric and adult patients. Immunological factors in these processes include molecular mimicry, hyperactivation of the immune system, and others. Moreover, a new clinical entity (Multisystem Inflammatory Syndrome in Children (MIS-C)) is an example of a severe immunologic mediated pattern after COVID-19. Objective: This review describes available evidence regarding the impact of COVID-19 infection on the occurrence and course of autoimmune diseases in children as well as in adults. Significant emphasis is placed on population studies regarding the diagnosis of autoimmune diseases and their natural history, the immunological mechanisms, and the impact of COVID-19 vaccination in the setting of autoimmunity. Methods: This review was conducted using findings of scientific search databases PubMed, Google Scholar and Scopus with words: COVID-19, SARS-CoV-2, autoimmunity, autoimmune diseases, rheumatic diseases, COVID-19 vaccination, MIS-C, molecular mimicry. Articles were selected based on relevance, methodological quality, and adherence to PRISMA 2020 guidelines. Results: The immune dysregulation of SARS-CoV-2 infection might induce the onset of autoimmune diseases. Increased rates of newly diagnosed autoimmune diseases, such as type 1 diabetes, systemic lupus erythematosus (SLE), and rheumatoid arthritis (RA), have been reported in both adult and pediatric populations following COVID-19. While autoimmune phenomena may rarely occur with COVID-19 vaccines, the risk is much higher with natural infection. Conclusion: Further studies and systematic immunological follow-up of patients after COVID-19 are essential for the early detection and effective management of autoimmune complication.